Publication | Closed Access

The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms

EconomicsMergers And AcquisitionsPatent ProsecutionGeneric EntryPatent DraftingBusinessLawTherapeutic PatentPatentabilityBrand Pharmaceutical FirmsBusiness Method PatentParagraph Iv DecisionsMarketingIntellectual PropertyPatent Analysis